Spaulding Rehabilitation Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Spaulding Rehabilitation Hospital sits in the top decile of US sponsors by registered trial count (#239 of 15,742 sponsors by registered trial count).
Spaulding Rehabilitation Hospital: 101 sponsored US clinical trials, 19 recruiting.
Spaulding Rehabilitation Hospital sponsors 101 registered US clinical trials on ClinicalTrials.gov, 19 of them currently recruiting, and 52 completed. 1 of these trials are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Spinal Cord Injuries, with 9 trials.
Top-decile sponsor footprint
Spaulding Rehabilitation Hospital ranks in the top decile of sponsors by registered trial count (#239 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
52 of 68 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (76.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 8 |
| Phase 3 | 1 |
Therapeutic Areas
What is open in the Spaulding Rehabilitation Hospital pipeline
19 recruiting of 101 indexed (19% open); 52 completed (51%).
Phase mix: 1 late (III/IV) vs 12 early (I/II) (early-phase heavy).
Top condition: Spinal Cord Injuries (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Spaulding Rehabilitation Hospital: open-pipeline peers nationwide
Peers matched on 101 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Spaulding Rehabilitation Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 101 trials (± recruiting share)
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · 102 trials · 0% recruiting
- UCB Pharma · 100 trials · 0% recruiting
- Wake Forest University · 100 trials · 7% recruiting
- Butler Hospital · 103 trials · 9% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Medical University of South Carolina · 19% recruiting · 755 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Spaulding Rehabilitation Hospital page
101 registered trials is a research-attention snapshot, not an endorsement of Spaulding Rehabilitation Hospital or any single study.
- 19 of Spaulding Rehabilitation Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Spinal Cord Injuries is the condition Spaulding Rehabilitation Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Spinal Cord Injuries trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Spaulding Rehabilitation Hospital pipeline card: 101 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.